Do patents with different indications but the same preparation constitute infringement?

Does not constitute. According to public information, when the patent protection of the original drug expires, its subsequent approved indications will form an independent patent. Therefore, generic drug manufacturers can imitate without infringing patents, but they cannot involve indications protected by patents. If generic drugs contain new patent marks in their product information, it constitutes patent infringement.